Psychiatry
Systematic Review | Predictors of burnout among healthcare providers.
31 Aug, 2022 | 11:50h | UTCPredictors of burnout among US healthcare providers: a systematic review – BMJ Open
Commentary on Twitter
Workload, work/life balance, job autonomy and perceived support from leadership, have strong associations with risk for burnout in US healthcare providers. https://t.co/GjseiefjM7 pic.twitter.com/uisEcTs7Lk
— BMJ_Open (@BMJ_Open) August 25, 2022
Study Commentary | Self-harm in autistic people: meta-analysis confirms higher risk compared to non-autistic people.
31 Aug, 2022 | 11:44h | UTCOriginal Article: Risk of Self-harm in Children and Adults With Autism Spectrum Disorder: A Systematic Review and Meta-analysis – JAMA Network Open
M-A | Family history of psychiatric disorders as a risk factor for maternal postpartum depression.
26 Aug, 2022 | 13:04h | UTCFamily History of Psychiatric Disorders as a Risk Factor for Maternal Postpartum Depression: A Systematic Review and Meta-analysis – JAMA Psychiatry (link to abstract – $ for full-text)
Commentaries:
Family History of Mental Illness Ups Odds for Postpartum Depression – HealthDay
Commentary on Twitter
Based on 26 studies from 18 countries, this systematic review and meta-analysis highlighted that mothers with a family history of any psychiatric disorder had an almost doubled risk of developing postpartum #depression compared to mothers without. https://t.co/zEJd6YHe71
— JAMA Psychiatry (@JAMAPsych) August 20, 2022
RCT | In patients with alcohol use disorder, the percentage of heavy drinking days was reduced with a psychedelic drug.
25 Aug, 2022 | 12:10h | UTCNews Release: Psychedelic drug therapy may help treat alcohol addiction – NYU Grossman School of Medicine
Commentary on Twitter:
In adults with alcohol-dependence, two doses of #psilocybin in combination with psychotherapy produced robust decreases in drinking relative to the outcomes observed with placebo and psychotherapy. https://t.co/M8PCbfwmWn #Research pic.twitter.com/duCJUL0jhx
— JAMA Psychiatry (@JAMAPsych) August 24, 2022
Study Commentary | Digital youth mental health interventions: will the evidence ever catch up?
25 Aug, 2022 | 11:54h | UTCDigital youth mental health interventions: will the evidence ever catch up? – The Mental Elf
Original Study: Evidence on Digital Mental Health Interventions for Adolescents and Young People: Systematic Overview – JMIR Mental Health
Guideline | Management of eating disorders for people with higher weight.
22 Aug, 2022 | 12:11h | UTC
Not too much, not too often, and not too many: the results of the first large-scale, international project to develop lower-risk gambling guidelines.
22 Aug, 2022 | 12:10h | UTC
Developmental variability in autism across 17.000 autistic individuals and 4.000 siblings without an autism diagnosis: comparisons by cohort, intellectual disability, genetic etiology, and age at diagnosis.
19 Aug, 2022 | 16:06h | UTCDevelopmental Variability in Autism Across 17 000 Autistic Individuals and 4000 Siblings Without an Autism DiagnosisComparisons by Cohort, Intellectual Disability, Genetic Etiology, and Age at Diagnosis – JAMA Pediatrics (link to abstract – $ for full-text)
Commentary: Timing of developmental milestones varies greatly in children with autism – Physician’s Weekly
Commentary on Twitter
When do individuals with autism spectrum disorder (ASD) attain developmental milestones? The timing varies greatly depending on whether they have intellectual disability, a neurodevelopmental disorder-linked rare genetic variant, or an early ASD diagnosis. https://t.co/7DRz5EueDZ
— JAMA Pediatrics (@JAMAPediatrics) July 18, 2022
Commentary on Twitter
When do individuals with autism spectrum disorder (ASD) attain developmental milestones? The timing varies greatly depending on whether they have intellectual disability, a neurodevelopmental disorder-linked rare genetic variant, or an early ASD diagnosis. https://t.co/7DRz5EueDZ
— JAMA Pediatrics (@JAMAPediatrics) July 18, 2022
Neurological and psychiatric risk trajectories after SARS-CoV-2 infection: an analysis of 2-year retrospective cohort studies including 1 284 437 patients.
18 Aug, 2022 | 12:49h | UTC
Commentary on Twitter
NEW—People with #COVID19 continue to face increased risks of some neurological and psychiatric conditions up to 2 years after infection, according to a study published in @TheLancetPsych: https://t.co/9fD5zMU3hE pic.twitter.com/8YhTKJ9v72
— The Lancet (@TheLancet) August 17, 2022
Guideline | Recommendation on instrument-based screening for depression during pregnancy and the postpartum period.
17 Aug, 2022 | 14:39h | UTCSee also: Canadian Task Force on Preventive Health Care page with summary and tools
Launch of first WHO position paper on optimizing brain health across life.
17 Aug, 2022 | 14:41h | UTCNews Release: Launch of first WHO position paper on optimizing brain health across life – World Health Organization
WHO position paper: Optimizing brain health across the life course – World Health Organization
Commentary on Twitter (thread – click for more)
Optimizing #BrainHealth ?
▶️reduces the burden of neurological disorders
▶️improves mental + physical health
▶️creates positive social & economic impactscontributing to greater well-being, advancing society. ?https://t.co/kVPgcFxBPG
— World Health Organization (WHO) (@WHO) August 9, 2022
Study suggests long covid symptoms affect 1 in 8 patients.
16 Aug, 2022 | 13:52h | UTCNews Release: Most reliable estimates to date suggest one in eight COVID-19 patients develop long COVID symptoms – Lancet
Commentaries:
Long COVID symptoms affect 1 in 8 adults, some for 2 years – CIDRAP
Covid-19: One in eight adults develops long covid symptoms, study suggests – The BMJ
Living through the psychological consequences of COVID-19 pandemic: a systematic review of effective mitigating interventions.
16 Aug, 2022 | 13:43h | UTC
RCT | Therapist-supported internet-delivered exposure and response prevention for children and adolescents with Tourette Syndrome.
16 Aug, 2022 | 13:18h | UTCCommentaries:
Online Exposure Therapy Improves Tic Symptoms in Youth – Psychiatric News Alert
Commentary on Twitter
In this RCT, 221 youths with #Tourette syndrome or chronic tic disorder received therapist-supported, internet-delivered exposure and response prevention (ERP) or education. Both groups improved over time, with no between-group differences in tic severity. https://t.co/YND2mgPn2Q
— JAMA Network Open (@JAMANetworkOpen) August 15, 2022
Cohort Study | Clinical correlates and outcomes of methamphetamine‐associated cardiovascular diseases in hospitalized patients.
16 Aug, 2022 | 13:03h | UTCCommentary: Methamphetamine use associated with cardiovascular disease in hospitalized patients – Physician’s Weekly
Commentary on Twitter
In one of the largest studies to date, Curran et al. found that #methamphetamine use is as big a risk for #heart #disease as alcohol and cocaine. @UCSFCardiology @LaraGroom #AHAJournals https://t.co/S82YLoVM7r pic.twitter.com/SkmxF3bG7d
— JAHA (@JAHA_AHA) August 12, 2022
Non-parenteral Ketamine for depression: a practical discussion on addiction potential and recommendations for judicious prescribing.
10 Aug, 2022 | 12:19h | UTC
RCT | Effectiveness of Varenicline and Cytisine for alcohol use reduction among people with HIV and substance use.
9 Aug, 2022 | 12:35h | UTC
Commentary on Twitter
In this RCT, varenicline and cytisine were not more efficacious than nicotine to treat risky drinking and smoking among individuals with HIV; rates of behavior change for alcohol consumption and smoking were high in all treatment groups. #OrigInvestigation https://t.co/h8M6e5nOkf
— JAMA Network Open (@JAMANetworkOpen) August 5, 2022
Real-world effectiveness of antipsychotic doses for relapse prevention in patients with first-episode schizophrenia in Finland: a nationwide, register-based cohort study.
5 Aug, 2022 | 14:31h | UTCReal-world effectiveness of antipsychotic doses for relapse prevention in patients with first-episode schizophrenia in Finland: a nationwide, register-based cohort study – The Lancet Psychiatry (link to abstract – $ for full-text)
Commentary on Twitter (thread – click for more)
cohort study in 1st-episode schizophrenia: The effectiveness of antipsychotics for relapse prevention decreased after the 2nd relapse. The aHR for rehospitalisation with AP use versus non-use increased from 0·42 to 0·78 after the 2nd relapse (p<0·0001) https://t.co/IBhDPNJJpe?
— PfOL (@psychopharmacol) March 18, 2022
Review | Adults with intellectual disabilities and mental health disorders in primary care.
5 Aug, 2022 | 14:24h | UTC
Review | Recognizing and managing eating disorders in the emergency department.
5 Aug, 2022 | 14:22h | UTCRecognising and managing eating disorders in the emergency department – Postgraduate Medical Journal
Cohort Study | The risk of opioid overdose is increased with concomitant use of oxycodone and selective serotonin reuptake inhibitors that are inhibitors of oxycodone metabolism.
4 Aug, 2022 | 14:27h | UTCCommentary from the author: Taking certain opioids while on commonly prescribed antidepressants may increase the risk of overdose – The Conversation
Commentary on Twitter
This cohort study found that concomitant use of oxycodone with potent CYP2D6-inhibiting serotonin reuptake inhibitors (SSRIs, eg. fluoxetine or paroxetine) is associated with an increased risk of overdose. https://t.co/Eol89RHWAu
— JAMA Network Open (@JAMANetworkOpen) February 24, 2022
Cohort Study | Bariatric surgery linked to doubling chance of marriage or divorce.
4 Aug, 2022 | 14:16h | UTCNews Release: Bariatric Surgery Linked to Doubling Chance of Marriage or Divorce – University of Pittsburgh
Commentary: Spouse Getting Weight Loss Surgery? Your Marriage Might Be in Trouble – HealthDay
RCT | Transcranial direct current stimulation vs. sham for the treatment of inattention in adults with attention-deficit/hyperactivity disorder.
4 Aug, 2022 | 13:50h | UTCTranscranial Direct Current Stimulation vs Sham for the Treatment of Inattention in Adults With Attention-Deficit/Hyperactivity Disorder: The TUNED Randomized Clinical Trial – JAMA Psychiatry (free for a limited period)
See also: Visual Abstract
M-A | Response to acute monotherapy for major depressive disorder in randomized, placebo controlled trials.
3 Aug, 2022 | 14:31h | UTC
M-A | Prevalence of suicidal ideation and self-harm behaviors in children aged 12 years and younger.
1 Aug, 2022 | 12:01h | UTCPrevalence of suicidal ideation and self-harm behaviours in children aged 12 years and younger: a systematic review and meta-analysis – The Lancet Psychiatry (link to abstract – $ for full-text)
Commentary on Twitter
*New* systematic review & meta-analysis estimates a prevalence of 7·5% for suicidal ideation, 2·2% for suicide planning, 1·4% for self-harm, 1·3% for suicide attempts, & 21·9% for non-suicidal self-injury in children aged ≤12 years
In @TheLancetPsych #childhoodsuicide https://t.co/wFbv6eKpNs
— The Lancet Child & Adolescent Health (@LancetChildAdol) July 28, 2022